allylamine has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Ron, P; Fleming, A; Fleurance, R; Gryshkova, V; McGhan, P; Nogueira da Costa, A; Valentin, JP | 1 |
| De Ron, P; Dremier, S; Glineur, SF; Hanon, E; Nogueira da Costa, A; Valentin, JP | 1 |
2 other study(ies) available for allylamine and Cardiotoxicity
| Article | Year |
|---|---|
miR-21-5p as a potential biomarker of inflammatory infiltration in the heart upon acute drug-induced cardiac injury in rats.
Topics: Allylamine; Animals; Cardiotoxicity; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Genetic Markers; Heart Diseases; In Situ Hybridization; Inflammation; Isoproterenol; Male; MicroRNAs; Multiplex Polymerase Chain Reaction; Myocardium; Oligonucleotide Array Sequence Analysis; Rats, Wistar; Risk Assessment; STAT3 Transcription Factor; Time Factors | 2018 |
Paving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.
Topics: Acute Disease; Allylamine; Animals; Biomarkers; Cardiotoxicity; Isoproterenol; Male; MicroRNAs; Rats; Rats, Wistar; Troponin I; Troponin T | 2016 |